HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.07-097428v1 22/6/1790    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Chen, G. Articles by Kranias, E. G. PubMed PubMed Citation Articles by Chen, G. Articles by Kranias, E. G.

A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to β-adrenergic stimulation

Guoli Chen^*, Xiaoyang Zhou^*, Persoulla Nicolaou^*, Patricia Rodriguez^*, Guojie Song^*,, Bryan Mitton^*, Anand Pathak^*, Amit Zachariah^*, Guo-Chang Fan^*, Gerald W. Dorn, II and Evangelia G. Kranias^*,,1

^* Department of Pharmacology and Cell Biophysics and

Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA;

Jiaxing University College of Medicine, Jiaxing, China; and

Molecular Biology Division, Center for Basic Research, Foundation for Biomedical Research of the Academy of Athens, Soranou Efesiou, Athens, Greece

¹Correspondence: Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0575, USA. E-mail: litsa.kranias{at}uc.edu

Aberrant β-adrenergic signaling and depressed calcium homeostasis, associated with an imbalance of protein kinase A and phosphatase-1 activities, are hallmarks of heart failure. Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI-1). We assessed 352 normal subjects, along with 959 patients with heart failure and identified a polymorphism in PPI-1 (G147D) exclusively in black subjects. To determine whether the G147D variant could affect cardiac function, we infected adult cardiomyocytes with adenoviruses expressing D147 or wild-type (G147) PPI-1. Under basal conditions, there were no significant differences in fractional shortening or contraction or relaxation rates. However, the enhancement of contractile parameters after isoproterenol stimulation was significantly blunted in D147 compared with G147 and control myocytes. Similar findings were observed in calcium kinetics. The attenuated β-agonist response was associated with decreased (50%) phosphorylation of phospholamban (PLN) at serine 16, whereas phosphorylation of troponin I and ryanodine receptor was unaltered. These findings suggest that the human G147D PPI-1 can attenuate responses of cardiomyocytes to β-adrenergic agonists by decreasing PLN phosphorylation and therefore may contribute to deteriorated function in heart failure.—Chen, G., Zhou, X., Nicolaou, P., Rodriguez, P., Song, G., Mitton, B., Pathak, A., Zachariah, A., Fan, G.-C., Dorn, G. A., II., Kranias, E. G. A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to β-adrenergic stimulation.

Key Words: cardiac function • phospholamban • heart failure